Clinical penetrance of C282Y homozygous HFE hemochromatosis

References

• Feder JN, Gnirke A, Thomas W et al. A novel MHC class 1-like gene is mutated in patients with hereditary haemochromatosis. Nat. Genet.13, 399–408 (1996).
   PubMed Web of Science ®Google Scholar
• Olynyk JK, Cullen DJ, Aquilia S, Rossi E, Summerville L, Powell LW. A population-based study of the clinical expression of the hemochromatosis gene. N. Engl. J. Med.341, 718–724 (1999).
   PubMed Web of Science ®Google Scholar
• Rossi E, Henderson S, Chin CYB et al. Genotyping as a diagnostic aid in genetic haemochromatosis. J. Gastro. Hepatol.14, 427–430 (1999).
   PubMed Web of Science ®Google Scholar
• Pietrangelo A. Hereditary hemochromatosis – a new look at an old disease. N. Engl. J. Med.350, 2383–2397 (2004).
   PubMed Web of Science ®Google Scholar
• Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T. Penetrance of 845G-->A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet359(9302), 211–218 (2002).
   PubMed Web of Science ®Google Scholar
• Whitlock EP, Garlitz BA, Harris EL, Beil TL, Smith PR. Screening for hereditary hemochromatosis: a systematic review for the US Preventive Services Task Force. Ann. Intern. Med.145, 209–223 (2006).
   PubMed Web of Science ®Google Scholar
• Ayonrinde OT, Olynyk JK. Clinical expression of hemochromatosis gene (HFE) variants. Hepatology46, 960–962 (2007).
   PubMed Web of Science ®Google Scholar
• Lim EM, Rossi E, De Boer WB, Reed WD, Jeffrey GP. Hepatic iron loading in patients with compound heterozygous HFE mutations. Liver Intern.24, 631–636 (2004).
   PubMed Web of Science ®Google Scholar
• Olynyk JK. Hereditary haemochromatosis: diagnosis and management in the gene era. Liver19, 73–80 (1999).
   PubMedGoogle Scholar
• Gochee PA, Powell LW, Cullen DJ, Du Sart D, Rossi E, Olynyk JK. A population-based study of the biochemical and clinical expression of the H63D hemochromatosis mutation. Gastroenterology122, 646–651 (2002).
   PubMed Web of Science ®Google Scholar
• Allen KJ, Gurrin LC, Constantine CC et al. Iron-overload-related disease in HFE hereditary hemochromatosis. N. Engl. J. Med.358(3), 221–230 (2008).
   PubMed Web of Science ®Google Scholar
• Walsh A, Dixon JL, Ramm GA et al. The clinical relevance of compound heterozygosity for the C282Y and H63D substitutions in hemochromatosis. Clin. Gastroenterol. Hepatol.4(11), 1403–1410 (2006).
   PubMed Web of Science ®Google Scholar
• Crawford DH, Jazwinska EC, Cullen LM, Powell LW. Expression of HLA-linked hemochromatosis in subjects homozygous or heterozygous for the C282Y mutation. Gastroenterology114(5), 1003–1008 (1998).
   PubMed Web of Science ®Google Scholar
• Adams PC, Gregor JC, Kertesz AE, Valberg LS. Screening blood donors for hereditary hemochromatosis: decision analysis model based on a 30-year database. Gastroenterology109(1), 177–188 (1995).
   PubMed Web of Science ®Google Scholar
• Adams PC, Reboussin DM, Barton JC et al. Hemochromatosis and iron-overload screening in a racially diverse population. N. Engl. J. Med.352, 1769–1778 (2005).
   PubMed Web of Science ®Google Scholar
• Barton JC, Wiener HW, Acton RT, Go RC. HLA haplotype A*03-B*07 in hemochromatosis probands with HFE C282Y homozygosity: frequency disparity in men and women and lack of association with severity of iron overload. Blood Cells Mol. Dis.34, 38–47 (2005).
   PubMed Web of Science ®Google Scholar
• Cruz E, Melo G, Lacerda R, Almeida S, Porto G. The CD8+ T-lymphocyte profile as a modifier of iron overload in HFE hemochromatosis: an update of clinical and immunological data from 70 C282Y homozygous subjects. Blood Cells Mol. Dis.37(1), 33–39 (2006).
   PubMed Web of Science ®Google Scholar
• Olynyk JK, Hagan SE, Cullen DJ, Beilby J, Whittall DE. Evolution of untreated hereditary hemochromatosis in the Busselton population: a 17-year study. Mayo Clin. Proc.79(3), 309–313 (2004).
   PubMed Web of Science ®Google Scholar
• Yamashita C, Adams PC. Natural history of the C282Y homozygote for the hemochromatosis gene (HFE) with a normal serum ferritin level. Clin. Gastroenterol. Hepatol.1(5), 388–391 (2003).
   PubMed Web of Science ®Google Scholar
• Andersen RV, Tybjaerg-Hansen A, Appleyard M, Birgens H, Nordestgaard BG. Hemochromatosis mutations in the general population: iron overload progression rate. Blood103(8), 2914–2919 (2004).
   PubMed Web of Science ®Google Scholar
• Powell LW, Dixon JL, Ramm GA et al. Screening for hemochromatosis in asymptomatic subjects with or without a family history. Arch. Int. Med.166, 294–301 (2006).
   PubMedGoogle Scholar
• Gurrin LC, Osborne NJ, Constantine CC et al. The natural history of serum iron indices for HFE C282Y homozygosity associated with hereditary hemochromatosis. Gastroenterology DOI 10.1053/j.gastro.2008.08.056 (2008) (Epub ahead of print).
   Google Scholar
• Pankow JS, Boerwinkle E, Adams PC et al.HFE C282Y homozygotes have reduced low-density lipoprotein cholesterol: the Atherosclerosis Risk in Communities (ARIC) Study. Transl. Res.152(1), 3–10 (2008).
   PubMed Web of Science ®Google Scholar
• Guyader D, Jacquelinet C, Moirand R et al. Noninvasive prediction of fibrosis in C282Y homozygous hemochromatosis. Gastroenterology115(4), 929–936 (1998).
   PubMed Web of Science ®Google Scholar
• Bulaj ZJ, Ajioka RS, Phillips JD et al. Disease-related conditions in relatives of patients with hemochromatosis. N. Engl. J. Med.343(21), 1529–1535 (2000).
   PubMed Web of Science ®Google Scholar
• EASL International consensus conference on haemochromatosis. J. Hepatol.33, 485–504 (2000).
   PubMed Web of Science ®Google Scholar
• Brittenham GM, Badman DG. Noninvasive measurement of iron: report of an NIDDK workshop. Blood101, 15–19 (2003).
   PubMed Web of Science ®Google Scholar
• St Pierre TG, Clark PR, Chua-anusorn W et al. Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. Blood105, 855–861 (2005).
   PubMed Web of Science ®Google Scholar
• Adams PC. Is there a threshold of hepatic iron concentration that leads to cirrhosis in C282Y hemochromatosis? Am. J. Gastroenterol.96, 567–569 (2001).
   PubMed Web of Science ®Google Scholar
• Olynyk JK, St Pierre TG, Britton RS, Brunt EM, Bacon BR. Duration of hepatic iron exposure increases the risk of significant fibrosis in hereditary hemochromatosis: a new role for magnetic resonance imaging. Am. J. Gastroenterol.100, 837–841 (2005).
   PubMed Web of Science ®Google Scholar
• Beaton M, Guyader D, Deugnier Y, Moirand R, Chakrabarti S, Adams P. Noninvasive prediction of cirrhosis in C282Y-linked hemochromatosis. Hepatology36(3), 673–678 (2002).
   PubMed Web of Science ®Google Scholar
• Pietrangelo A. The penetrance of hemochromatosis: mice to the rescue. Gastroenterology132(2), 805–808 (2007).
   PubMed Web of Science ®Google Scholar
• Gouya L, Muzeau F, Robreau AM et al. Genetic study of variation in normal mouse iron homeostasis reveals ceruloplasmin as an HFE-hemochromatosis modifier gene. Gastroenterology132(2), 679–686 (2007).
   PubMed Web of Science ®Google Scholar
• Asberg A, Hveem K, Thorstensen K et al. Screening for hemochromatosis: high prevalence and low morbidity in an unselected population of 65,238 persons. Scand. J. Gastroenterol.36(10), 1108–1115 (2001).
   PubMed Web of Science ®Google Scholar
• Ellervik C, Birgens H, Tybjaerg-Hansen A, Nordestgaard BG. Hemochromatosis genotypes and risk of 31 disease endpoints: meta-analyses including 66,000 cases and 226,000 controls. Hepatology46(4), 1071–1080 (2007).
   PubMed Web of Science ®Google Scholar
• Adams PC, Kertesz AE, Valberg LS. Rate of iron reaccumulation following iron depletion in hereditary hemochromatosis. Implications for venesection therapy. J. Clin. Gastroenterol.16(3), 207–210 (1993).
   PubMed Web of Science ®Google Scholar
• Smith PM, Godfrey BE, Williams R. Iron absorption in idiopathic haemochromatosis and its measurement using a whole-body counter. Clin. Sci.37(2), 519–531 (1969).
   PubMed Web of Science ®Google Scholar
• Lynch SR, Skikne BS, Cook JD. Food iron absorption in idiopathic hemochromatosis. Blood74(6), 2187–2193 (1989).
   PubMed Web of Science ®Google Scholar
• McCune CA, Ravine D, Carter K et al. Iron loading and morbidity among relatives of HFE C282Y homozygotes identified either by population genetic testing or presenting as patients. Gut55(4), 554–562 (2006).
   PubMed Web of Science ®Google Scholar
• Milward EA, Baines SK, Knuiman MW et al. Noncitrus fruits as novel dietary environmental modifiers of iron stores in people with or without HFE gene mutations. Mayo Clin. Proc.83(5), 543–549 (2008).
   PubMed Web of Science ®Google Scholar
• Cade JE, Moreton JA, O’Hara B et al. Diet and genetic factors associated with iron status in middle-aged women. Am. J. Clin. Nutr.82(4), 813–820 (2005).
   PubMed Web of Science ®Google Scholar
• van der A DL, Peeters PH, Grobbee DE, Roest M, Voorbij HA, van der Schouw YT. HFE genotypes and dietary heme iron: no evidence of strong gene–nutrient interaction on serum ferritin concentrations in middle-aged women. Nutr. Metab. Cardiovasc. Dis.16(1), 60–68 (2006).
   PubMed Web of Science ®Google Scholar
• Bassett ML, Halliday JW, Powell LW. Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis. Hepatology6(1), 24–29 (1986).
   PubMed Web of Science ®Google Scholar
• Rossi E, Bulsara MK, Olynyk JK, Cullen DJ, Summerville L, Powell LW. The effect of haemochromatosis genotype and life-style factors on iron and red cell indices in a community population. Clin. Chem.47, 202–208 (2001).
   PubMed Web of Science ®Google Scholar
• Moirand R, Lescoat G, Delamaire D et al. Increase in glycosylated and nonglycosylated serum ferritin in chronic alcoholism and their evolution during alcohol withdrawal. Alcohol Clin. Exp. Res.15(6), 963–969 (1991).
   PubMed Web of Science ®Google Scholar
• Scotet V, Merour MC, Mercier AY et al. Hereditary hemochromatosis: effect of excessive alcohol consumption on disease expression in patients homozygous for the C282Y mutation. Am. J. Epidemiol.158(2), 129–134 (2003).
   PubMed Web of Science ®Google Scholar
• Fletcher LM, Dixon JL, Purdie DM, Powell LW, Crawford DH. Excess alcohol greatly increases the prevalence of cirrhosis in hereditary hemochromatosis. Gastroenterology122(2), 281–289 (2002).
   PubMed Web of Science ®Google Scholar
• Bridle K, Cheung TK, Murphy T et al. Hepcidin is down-regulated in alcoholic liver injury: implications for the pathogenesis of alcoholic liver disease. Alcohol Clin. Exp. Res.30(1), 106–112 (2006).
   PubMed Web of Science ®Google Scholar
• Harrison-Findik DD, Schafer D, Klein E et al. Alcohol metabolism-mediated oxidative stress down-regulates hepcidin transcription and leads to increased duodenal iron transporter expression. J. Biol. Chem.281(32), 22974–22982 (2006).
   PubMed Web of Science ®Google Scholar
• Whitfield JB, Cullen LM, Jazwinska EC et al. Effects of HFE C282Y and H63D polymorphisms and polygenic background on iron stores in a large community sample of twins. Am. J. Hum. Genet.66(4), 1246–1258 (2000).
   PubMed Web of Science ®Google Scholar
• Nemeth E, Tuttle MS, Powelson J et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science306(5704), 2090–2093 (2004).
   PubMed Web of Science ®Google Scholar
• Merryweather-Clarke AT, Cadet E, Bomford A et al. Digenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosis. Hum. Mol. Genet.12(17), 2241–2247 (2003).
   PubMed Web of Science ®Google Scholar
• Jacolot S, Le Gac G, Scotet V, Quere I, Mura C, Ferec C. HAMP as a modifier gene that increases the phenotypic expression of the HFE pC282Y homozygous genotype. Blood103(7), 2835–2840 (2004).
   PubMed Web of Science ®Google Scholar
• Le Gac G, Scotet V, Ka C et al. The recently identified type 2A juvenile haemochromatosis gene (HJV), a second candidate modifier of the C282Y homozygous phenotype. Hum. Mol. Genet.13(17), 1913–1918 (2004).
   PubMed Web of Science ®Google Scholar
• Milet J, Dehais V, Bourgain C et al. Common variants in the BMP2, BMP4, and HJV genes of the hepcidin regulation pathway modulate HFE hemochromatosis penetrance. Am. J. Hum. Genet.81(4), 799–807 (2007).
   PubMed Web of Science ®Google Scholar
• Lee PL, Gelbart T, West C, Halloran C, Felitti V, Beutler E. A study of genes that may modulate the expression of hereditary hemochromatosis: transferrin receptor-1, ferroportin, ceruloplasmin, ferritin light and heavy chains, iron regulatory proteins (IRP)-1 and -2, and hepcidin. Blood Cells Mol. Dis.27(5), 783–802 (2001).
   PubMed Web of Science ®Google Scholar
• Lee P, Gelbart T, West C, Halloran C, Beutler E. Seeking candidate mutations that affect iron homeostasis. Blood Cells Mol. Dis.29(3), 471–487 (2002).
   PubMed Web of Science ®Google Scholar
• Van Vlierberghe H, Langlois M, Delanghe J et al. Haptoglobin phenotype 2–2 overrepresentation in Cys282Tyr hemochromatotic patients. J. Hepatol.35(6), 707–711 (2001).
   PubMed Web of Science ®Google Scholar
• Piperno A, Arosio C, Fargion S et al. The ancestral hemochromatosis haplotype is associated with a severe phenotype expression in Italian patients. Hepatology24(1), 43–46 (1996).
   PubMed Web of Science ®Google Scholar
• Pratiwi R, Fletcher LM, Pyper WR et al. Linkage disequilibrium analysis in Australian haemochromatosis patients indicates bipartite association with clinical expression. J. Hepatol.31(1), 39–46 (1999).
   PubMed Web of Science ®Google Scholar
• Adams PC, Agnew S. Alcoholism in hereditary hemochromatosis revisited: prevalence and clinical consequences among homozygous siblings. Hepatology23(4), 724–727 (1996).
   PubMed Web of Science ®Google Scholar
• Tung BY, Emond MJ, Bronner MP, Raaka SD, Cotler SJ, Kowdley KV. Hepatitis C, iron status, and disease severity: relationship with HFE mutations. Gastroenterology124(2), 318–326 (2003).
   PubMed Web of Science ®Google Scholar
• Diwakaran HH, Befeler AS, Britton RS, Brunt EM, Bacon BR. Accelerated hepatic fibrosis in patients with combined hereditary hemochromatosis and chronic hepatitis C infection. J. Hepatol.36(5), 687–691 (2002).
   PubMed Web of Science ®Google Scholar
• Powell EE, Ali A, Clouston AD et al. Steatosis is a cofactor in liver injury in hemochromatosis. Gastroenterology129(6), 1937–1943 (2005).
   PubMed Web of Science ®Google Scholar
• Valenti L, Fracanzani AL, Dongiovanni P et al. Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study. Am. J. Gastroenterol.102(6), 1251–1258 (2007).
   PubMed Web of Science ®Google Scholar
• Di Martino V, Lebray P, Myers RP et al. Progression of liver fibrosis in women infected with hepatitis C: long-term benefit of estrogen exposure. Hepatology40(6), 1426–1433 (2004).
   PubMed Web of Science ®Google Scholar
• Loréal O, Deugnier Y, Moirand R et al. Liver fibrosis in genetic hemochromatosis. Respective roles of iron and non-iron-related factors in 127 homozygous patients. J. Hepatol.16(1–2), 122–127 (1992).
   PubMed Web of Science ®Google Scholar
• Shimizu I. Impact of oestrogens on the progression of liver disease. Liver Int.23(1), 63–69 (2003).
   PubMed Web of Science ®Google Scholar
• Osterreicher CH, Datz C, Stickel F et al. TGF-β1 codon 25 gene polymorphism is associated with cirrhosis in patients with hereditary hemochromatosis. Cytokine31(2), 142–148 (2005).
   PubMed Web of Science ®Google Scholar
• Fargion S, Valenti L, Dongiovanni P et al. Tumor necrosis factor α promoter polymorphisms influence the phenotypic expression of hereditary hemochromatosis. Blood97(12), 3707–3712 (2001).
   PubMed Web of Science ®Google Scholar
• Distante S, Elmberg M, Foss Haug KB et al. Tumour necrosis factor α and its promoter polymorphisms’ role in the phenotypic expression of hemochromatosis. Scand. J. Gastroenterol.38(8), 871–877 (2003).
   PubMed Web of Science ®Google Scholar
• Beutler E, Gelbart T. Tumor necrosis factor α promoter polymorphisms and liver abnormalities of homozygotes for the 845G>A (C282Y) hereditary hemochromatosis mutation. Blood100(6), 2268–2269 (2002).
   PubMed Web of Science ®Google Scholar
• Marra F, DeFranco R, Grappone C et al. Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: correlation with monocyte infiltration. Am. J. Pathol.152(2), 423–430 (1998).
   PubMed Web of Science ®Google Scholar
• Mühlbauer M, Bosserhoff AK, Hartmann A et al. A novel MCP-1 gene polymorphism is associated with hepatic MCP-1 expression and severity of HCV-related liver disease. Gastroenterology125(4), 1085–1093 (2003).
   PubMed Web of Science ®Google Scholar
• Stickel F, Osterreicher CH, Datz C et al. Prediction of progression to cirrhosis by a glutathione S-transferase P1 polymorphism in subjects with hereditary hemochromatosis. Arch. Intern. Med.165(16), 1835–1840 (2005).
   PubMedGoogle Scholar
• Osterreicher CH, Datz C, Stickel F et al. Association of myeloperoxidase promotor polymorphism with cirrhosis in patients with hereditary hemochromatosis. J. Hepatol.42(6), 914–919 (2005).
   PubMed Web of Science ®Google Scholar